View Older Stories View More Recent Stories
-
Apertura Gene Therapy Showcases the Progress of its Novel Human Transferrin Receptor AAV Capsid, TfR1 CapX, and Preclinical Programs for Tuberous Sclerosis Complex (TSC) at the American Society of Gen
-
Cure® Announces 2025 XSeed Award Winners, Advancing Minority- and Women-Led Life Science Startups in New York City
-
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Updates
-
Deerfield Management Closes Over $600 Million Healthcare Venture Fund
-
Atlas Data Storage Announces Initial Close of Seed Financing
-
Twist Bioscience Corporation (TWST) Spins Out DNA Data Storage as Independent Company
-
Twist Bioscience Spins Out DNA Data Storage as Independent Company
-
Element Science Receives FDA Approval for the Revolutionary Jewel® Patch Wearable Cardioverter Defibrillator
-
Apertura Gene Therapy and Rett Syndrome Research Trust Collaborate to Pioneer Advanced Genetic Medicines for Rett Syndrome Using TfR1-Targeted AAV Capsid
-
Adela Presents Data Demonstrating Ability of Tissue-Free MRD Test to Predict Recurrence in Lung Cancer at the American Association for Cancer Research Annual Meeting 2025
-
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
-
Ascertain Raises $10 Million in Series A Funding to Scale Agentic AI Platform
-
Deerfield Management Welcomes Mark Michalski, M.D., as Chief Information Officer
-
Form 4 BiomX Inc. For: Apr 14 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Cohere Health Strengthens Clinical Expertise with Addition of Dr. Paul Johnson to its Medical Advisory Board
-
Deerfield Management Supports Brookdale Senior Living
-
Adela's Co-Founder & Chief Scientific Officer, Dr. Daniel De Carvalho, Receives 2025 Canada Gairdner Momentum Award Recognizing World-Renowned Scientists for Exceptional Scientific Research Contri
-
Cohere Health Launches Cohere Align to Move Beyond Gold Carding with Smarter Prior Authorization for Health Plans
-
The Oncology Institute (TOI) Announces $16.5M Private Placement
-
The Oncology Institute Announces $16.5 million Private Placement
-
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
-
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
-
Cure© Hosts Power of X Summit to Drive Investment and Solutions in Untapped Trillion-Dollar Market Addressing Health of Women
-
Apertura Gene Therapy Supports the Broad Institute in Development of Gene Therapy for Prion Disease Using Engineered AAV Capsid Targeting TfR1 for CNS Delivery
-
BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB)
-
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Tar
-
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million
-
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown
-
Deerfield Management Announces Collaboration with QIA as Part of its Fund of Funds VC Program and the Opening of a Regional Office in Doha
-
Singular Genomics Announces Closing of Acquisition by Deerfield Management
-
Perceive Pharma Attracts $15M Series A Financing to Advance Ophthalmic Neuroprotection
-
Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
-
Cohere Health Unveils Cohere Connect™ to Address Prior Authorization Compliance Gaps for Health Plans
-
Form 4 Acutus Medical, Inc. For: Jan 27 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
The University of Chicago and Deerfield Management launch Hyde Park Discovery to accelerate translation of research into life-saving treatments
-
AbbVie (ABBV) and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
-
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
-
Deerfield Foundation Awards $1.5 Million to Improve Health, Accelerate Innovation, and Promote Equity
-
Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer
-
Cohere Health Achieves Significant Growth in 2024, Accelerating Momentum as the Leader in AI-Driven Clinical Intelligence
-
Nema Health Raises $14.5 Million Series A to Expand Virtual PTSD Treatment Model and Promote Long-Term Healing
-
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Endologix Announces Leadership Transition
-
CURE® AND DEERFIELD MANAGEMENT OPEN 2025 XSEED AWARD APPLICATIONS
-
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Singular Genomics Systems, Inc. Buyout
-
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Singular Genomics Systems, Inc. (Nasdaq - OMIC), Nordstrom, Inc. (NYSE - JWN), Despegar.com, Corp. (NYSE - DESP
-
Singular Genomics Systems (OMIC) Acquired by Deerfield for $20/sh Cash
-
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
-
Pleno, Inc. Appoints Dr. Vik Vaz, M.D. as Chief Executive Officer & President to Drive Commercial Growth After Closing $25M Series B Funding
-
InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO
